Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.

Bibert, Stéphanie; Guex, Nicolas; Lourenco, Joao; Brahier, Thomas; Papadimitriou-Olivgeris, Matthaios; Damonti, Lauro; Manuel, Oriol; Liechti, Robin; Götz, Lou; Tschopp, Jonathan; Quinodoz, Mathieu; Vollenweider, Peter; Pagani, Jean-Luc; Oddo, Mauro; Hügli, Olivier; Lamoth, Frédéric; Erard, Véronique; Voide, Cathy; Delorenzi, Mauro; Rufer, Nathalie; ... (2021). Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Frontiers in immunology, 12, p. 666163. Frontiers Research Foundation 10.3389/fimmu.2021.666163

[img]
Preview
Text
fimmu-12-666163.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (11MB) | Preview

The reason why most individuals with COVID-19 have relatively limited symptoms while other develop respiratory distress with life-threatening complications remains unknown. Increasing evidence suggests that COVID-19 associated adverse outcomes mainly rely on dysregulated immunity. Here, we compared transcriptomic profiles of blood cells from 103 patients with different severity levels of COVID-19 with that of 27 healthy and 22 influenza-infected individuals. Data provided a complete overview of SARS-CoV-2-induced immune signature, including a dramatic defect in IFN responses, a reduction of toxicity-related molecules in NK cells, an increased degranulation of neutrophils, a dysregulation of T cells, a dramatic increase in B cell function and immunoglobulin production, as well as an important over-expression of genes involved in metabolism and cell cycle in patients infected with SARS-CoV-2 compared to those infected with influenza viruses. These features also differed according to COVID-19 severity. Overall and specific gene expression patterns across groups can be visualized on an interactive website (https://bix.unil.ch/covid/). Collectively, these transcriptomic host responses to SARS-CoV-2 infection are discussed in the context of current studies, thereby improving our understanding of COVID-19 pathogenesis and shaping the severity level of COVID-19.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Damonti, Lauro (B)

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1664-3224

Publisher:

Frontiers Research Foundation

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

16 Dec 2021 10:58

Last Modified:

29 Mar 2023 23:38

Publisher DOI:

10.3389/fimmu.2021.666163

PubMed ID:

34135895

Uncontrolled Keywords:

COVID-19 RNA-sequencing SARS-CoV-2 immune profiling influenza whole blood transcriptome

BORIS DOI:

10.48350/161982

URI:

https://boris.unibe.ch/id/eprint/161982

Actions (login required)

Edit item Edit item
Provide Feedback